Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Change in Account Payables: 2019-2025

Historic Change in Account Payables for Kymera Therapeutics (KYMR) over the last 6 years, with Sep 2025 value amounting to -$267,000.

  • Kymera Therapeutics' Change in Account Payables fell 390.22% to -$267,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$988,000, marking a year-over-year decrease of 157.14%. This contributed to the annual value of -$307,000 for FY2024, which is 115.06% down from last year.
  • Per Kymera Therapeutics' latest filing, its Change in Account Payables stood at -$267,000 for Q3 2025, which was up 93.54% from -$4.1 million recorded in Q2 2025.
  • In the past 5 years, Kymera Therapeutics' Change in Account Payables registered a high of $4.2 million during Q3 2022, and its lowest value of -$4.1 million during Q2 2025.
  • Over the past 3 years, Kymera Therapeutics' median Change in Account Payables value was $75,000 (recorded in 2024), while the average stood at $113,455.
  • Data for Kymera Therapeutics' Change in Account Payables shows a peak YoY increase of 5,122.67% (in 2025) and a maximum YoY decrease of 13,432.26% (in 2025) over the last 5 years.
  • Kymera Therapeutics' Change in Account Payables (Quarterly) stood at -$1.0 million in 2021, then crashed by 101.17% to -$2.1 million in 2022, then surged by 174.03% to $1.5 million in 2023, then plummeted by 132.98% to -$505,000 in 2024, then tumbled by 390.22% to -$267,000 in 2025.
  • Its Change in Account Payables was -$267,000 in Q3 2025, compared to -$4.1 million in Q2 2025 and $3.9 million in Q1 2025.